Table 1 Summary data for all patients
Variables | Value |
|---|---|
Biopsy (n, %) | |
Needle biopsy | 20 (80%) |
Excisional biopsy | 5 (20%) |
Pathological diagnoses (n, %) | |
Fibrosarcoma | 9 (36%) |
Synovial sarcoma | 5 (20%) |
Undifferentiated sarcoma | 3 (12%) |
Melanoma, | 3 (12%) |
Skin protuberant fibrosarcoma | 2 (8%) |
Clear cell sarcoma | 2 (8%) |
Leiomyosarcoma | 1 (4%) |
Wound location (n, %) | |
Upper extremity | Forearm 3 (12%); upper arm 3 (12%) |
Lower extremity | Thigh 8 (32%), calf 6 (24%), feet 2 (8%) |
Trunk | Back 2 (8%), abdomen 1 (4%) |
Wound size (cm) | |
Length: range, mean (SD) cm | 3.5–19, 10.1 (4.1) |
Width: range, mean (SD) cm | 1.5–11, 6.1 (2.9) |
Skin stretching (n, %) | |
Intraoperative stretching | 7 (28%) |
Postoperative stretching | 18 (72%) |
Time to start postoperative chemo and/or radio | |
Range, mean (SD) days | 18–31, 23.2 (4.5) |
Follow-up time: range, mean (SD) months | 16-36, 25.6 (3.7) |
Complications (n, %) | |
Minor superficial wound infection | 6 (24%) |
Wound edge ischemia | 2 (8%) |
Small skin tears | 2 (8%) |
Survival status (n, %) | |
DFS | 20 (80%) |
AWD | 4 (16%; 2 with pulmonary metastasis, 2 with local recurrence) |
DOD | 1 (4%) |